Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-11 Sale |
2021-05-13 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
2,146 | $19.58 | $42,023 | 186,794 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $26.23 | $262,300 | 328,940 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-19 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
17,727 | $27.44 | $486,456 | 338,940 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-18 6:26 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
2,500 | $28.01 | $70,025 | 34,832 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:32 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
2,250 | $31.5 | $70,864 | 46,344 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:31 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
2,250 | $31.5 | $70,864 | 59,344 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:30 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
4,500 | $31.5 | $141,728 | 37,332 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:30 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
4,500 | $31.5 | $141,728 | 37,705 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:29 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,500 | $31.5 | $141,728 | 32,223 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:28 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,626 | $31.5 | $303,171 | 156,813 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,126 | $29.83 | $33,589 | 57,094 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $28.91 | $52,414 | 44,094 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:32 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,625 | $28.91 | $104,799 | 37,332 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:31 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,175 | $28.91 | $91,789 | 37,705 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:30 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
3,625 | $28.91 | $104,799 | 32,223 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
2,406 | $28.91 | $69,557 | 148,939 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:31 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $30.75 | $55,750 | 45,907 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:23 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,625 | $30.75 | $111,469 | 43,457 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:21 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,175 | $30.75 | $97,631 | 40,880 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:20 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
8,734 | $29.91 | $261,267 | 151,345 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:19 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
3,625 | $30.75 | $111,469 | 35,848 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:18 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $30.75 | $768,750 | 471,667 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:30 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,376 | $26.83 | $36,918 | 24,055 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
6,876 | $26.83 | $184,483 | 87,819 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-16 8:55 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
5,549 | $26.02 | $144,385 | 196,667 (Direct) |
View |
| 2020-12-02 Sale |
2020-12-04 7:00 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
7,891 | $23.43 | $184,849 | 202,216 (Direct) |
View |
| 2020-11-24 Sale |
2020-11-25 7:00 pm |
Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $23.29 | $174,675 | 19,473 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-16 Exercise |
2021-04-20 4:05 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $0 | 328,940 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $16.23 | 328,940 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-19 4:05 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $0 | 338,940 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-19 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $16.23 | 338,940 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:49 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
4,500 | $0 | 48,594 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:49 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
4,500 | $0 | 41,832 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:48 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
4,500 | $0 | 61,594 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:47 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
4,500 | $0 | 42,205 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:46 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,500 | $0 | 36,723 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:46 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,500 | $0 | 166,439 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:31 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
5,000 | $0 | 45,907 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:23 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
5,000 | $0 | 43,457 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:21 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
5,000 | $0 | 40,880 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
15,000 | $0 | 151,345 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:19 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
5,000 | $0 | 35,848 (Direct) |
View |
| 2021-02-21 Exercise |
2021-02-02 9:18 pm |
N/A 2024-11-05 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $0 | 471,667 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-02 9:18 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $10.09 | 471,667 (Direct) |
View |
| 2021-01-21 Option Award(A) |
2021-01-28 8:00 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
212,660 | $0 | 212,660 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:58 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
72,500 | $0 | 97,082 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:57 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
72,500 | $0 | 100,220 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:56 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
72,500 | $0 | 96,555 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:55 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
72,500 | $0 | 115,720 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:55 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
72,500 | $0 | 91,973 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:54 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
269,860 | $0 | 357,679 (Direct) |
View |
| 2020-11-19 Gift |
2020-12-04 7:00 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
3,000 | $0 | 202,216 (Direct) |
View |
| 2020-11-23 Option Award |
2020-11-25 7:00 pm |
N/A N/A |
Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $0 | 19,473 (Direct) |
View |